Tanna works on organic and inorganic growth strategies
A special purpose vehicle owned by KKR-managed funds will acquire a controlling interest in Healthium group and further scale its global business through organic and inorganic growth strategies.
Akshay Tanna, Partner and Head of India Private Equity at KKR, said on 6 May 2024, “We look forward to leveraging our global network https://www.healthcare.gov/ and healthcare https://www.who.int/ expertise to accelerate its growth in this fast-growing sector and further scale its global business through organic and inorganic growth strategies.”
Founded in India in 1992, Healthium https://healthiummedtech.com/ is a medical devices company that develops, manufactures and sells a broad range of surgical products globally. Its comprehensive, high-quality portfolio caters to a wide spectrum of surgeons’ needs, offering wound closure, arthroscopy, and advanced wound closure products.
KKR has signed definitive agreements under which funds managed by KKR https://www.kkr.com/ will acquire Healthium Medtech Ltd from an affiliate of Funds advised by Apax Partners LLP, a leading global private equity advisory firm.
The Apax Funds https://www.apax.com/ acquired Healthium in 2018 and transformed the company from a domestic suture player into a leader in the global medical device industries. Since then, Healthium expanded its presence to more than 90 countries.
KKR makes its investment from its Asian Fund IV. Fiinews.com
